The comparative risk of acute kidney injury of vancomycin relative to other common antibiotics

The glycopeptide antibiotic vancomycin is a mainstay in the treatment of Gram-positive infection. While its association with acute kidney injury (AKI) has waxed and waned, recent data suggest nephrotoxicity, even as mono-therapy. Our study aimed to evaluate the 2-week risk of AKI after at least 3 da...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaggl, Martina, Pate, Virginia, Stürmer, Til, Kshirsagar, Abhijit V., Layton, J. Bradley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560595/
https://www.ncbi.nlm.nih.gov/pubmed/33057027
http://dx.doi.org/10.1038/s41598-020-73687-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560595/
https://www.ncbi.nlm.nih.gov/pubmed/33057027
http://dx.doi.org/10.1038/s41598-020-73687-9

Ejemplares similares